Differential Circulating Fungal Microbiome in Prostate Cancer Patients Compared to Healthy Control Individuals

Backgrounds. Infection and inflammation play an important role in prostate cancer (PCa) etiology and pathogenesis. However, the environmental drivers for PCa are not fully understood. Methods. In a cross-sectional study, we analyzed circulating fungal microbiome in plasma samples from age and race-m...

Full description

Saved in:
Bibliographic Details
Main Authors: Xu Wang, Zejun Zhou, David Turner, Michael Lilly, Tongwen Ou, Wei Jiang
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2022/2574964
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832550896123248640
author Xu Wang
Zejun Zhou
David Turner
Michael Lilly
Tongwen Ou
Wei Jiang
author_facet Xu Wang
Zejun Zhou
David Turner
Michael Lilly
Tongwen Ou
Wei Jiang
author_sort Xu Wang
collection DOAJ
description Backgrounds. Infection and inflammation play an important role in prostate cancer (PCa) etiology and pathogenesis. However, the environmental drivers for PCa are not fully understood. Methods. In a cross-sectional study, we analyzed circulating fungal microbiome in plasma samples from age and race-matched healthy control men (n=34) and preoperative PCa patients (n=31). Results. The fungal community in the plasma exhibited differences between individuals with PCa and healthy controls according to the beta diversity; there was no difference in the alpha diversity. Moreover, the relative abundance of several fungi differed between the two study groups from the class to species levels. The most significant differences were Filobasidiales family, Pyronemataceae family, and Cryptococcus ater species, which were enriched in PCa patients compared to controls. The increased Bipolaris genus was associated with low prostate-specific antigen (PSA) levels, increased Sordariomycetes class was associated with severe pathological stage, and decreased Phoma herbarum species was associated with disease relapse, compared to corresponding controls. Several fungi from class to species levels were increased in the controls compared to patients. Conclusion. This is the first study to show plasma distinct fungal microbiome and its associations with PSA levels, relapse, and pathology stages in PCa patients.
format Article
id doaj-art-3da3d394c59942ae94a7f40fde60c2e3
institution Kabale University
issn 2314-7156
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-3da3d394c59942ae94a7f40fde60c2e32025-02-03T06:05:32ZengWileyJournal of Immunology Research2314-71562022-01-01202210.1155/2022/2574964Differential Circulating Fungal Microbiome in Prostate Cancer Patients Compared to Healthy Control IndividualsXu Wang0Zejun Zhou1David Turner2Michael Lilly3Tongwen Ou4Wei Jiang5Department of Microbiology and ImmunologyState Key Laboratory of Developmental Biology of Freshwater FishDepartment of Pathology and Laboratory MedicineDivision of Hematology and OncologyDepartment of UrologyDepartment of Microbiology and ImmunologyBackgrounds. Infection and inflammation play an important role in prostate cancer (PCa) etiology and pathogenesis. However, the environmental drivers for PCa are not fully understood. Methods. In a cross-sectional study, we analyzed circulating fungal microbiome in plasma samples from age and race-matched healthy control men (n=34) and preoperative PCa patients (n=31). Results. The fungal community in the plasma exhibited differences between individuals with PCa and healthy controls according to the beta diversity; there was no difference in the alpha diversity. Moreover, the relative abundance of several fungi differed between the two study groups from the class to species levels. The most significant differences were Filobasidiales family, Pyronemataceae family, and Cryptococcus ater species, which were enriched in PCa patients compared to controls. The increased Bipolaris genus was associated with low prostate-specific antigen (PSA) levels, increased Sordariomycetes class was associated with severe pathological stage, and decreased Phoma herbarum species was associated with disease relapse, compared to corresponding controls. Several fungi from class to species levels were increased in the controls compared to patients. Conclusion. This is the first study to show plasma distinct fungal microbiome and its associations with PSA levels, relapse, and pathology stages in PCa patients.http://dx.doi.org/10.1155/2022/2574964
spellingShingle Xu Wang
Zejun Zhou
David Turner
Michael Lilly
Tongwen Ou
Wei Jiang
Differential Circulating Fungal Microbiome in Prostate Cancer Patients Compared to Healthy Control Individuals
Journal of Immunology Research
title Differential Circulating Fungal Microbiome in Prostate Cancer Patients Compared to Healthy Control Individuals
title_full Differential Circulating Fungal Microbiome in Prostate Cancer Patients Compared to Healthy Control Individuals
title_fullStr Differential Circulating Fungal Microbiome in Prostate Cancer Patients Compared to Healthy Control Individuals
title_full_unstemmed Differential Circulating Fungal Microbiome in Prostate Cancer Patients Compared to Healthy Control Individuals
title_short Differential Circulating Fungal Microbiome in Prostate Cancer Patients Compared to Healthy Control Individuals
title_sort differential circulating fungal microbiome in prostate cancer patients compared to healthy control individuals
url http://dx.doi.org/10.1155/2022/2574964
work_keys_str_mv AT xuwang differentialcirculatingfungalmicrobiomeinprostatecancerpatientscomparedtohealthycontrolindividuals
AT zejunzhou differentialcirculatingfungalmicrobiomeinprostatecancerpatientscomparedtohealthycontrolindividuals
AT davidturner differentialcirculatingfungalmicrobiomeinprostatecancerpatientscomparedtohealthycontrolindividuals
AT michaellilly differentialcirculatingfungalmicrobiomeinprostatecancerpatientscomparedtohealthycontrolindividuals
AT tongwenou differentialcirculatingfungalmicrobiomeinprostatecancerpatientscomparedtohealthycontrolindividuals
AT weijiang differentialcirculatingfungalmicrobiomeinprostatecancerpatientscomparedtohealthycontrolindividuals